227 related articles for article (PubMed ID: 21395503)
1. FGF signaling in craniofacial biological control and pathological craniofacial development.
Hatch NE
Crit Rev Eukaryot Gene Expr; 2010; 20(4):295-311. PubMed ID: 21395503
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor signaling in cranial suture development and pathogenesis.
Hajihosseini MK
Front Oral Biol; 2008; 12():160-177. PubMed ID: 18391500
[TBL] [Abstract][Full Text] [Related]
3. From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes.
Britto JA; Evans RD; Hayward RD; Jones BM
Plast Reconstr Surg; 2001 Dec; 108(7):2026-39; discussion 2040-6. PubMed ID: 11743396
[TBL] [Abstract][Full Text] [Related]
4. FGF signalling in craniofacial development and developmental disorders.
Nie X; Luukko K; Kettunen P
Oral Dis; 2006 Mar; 12(2):102-11. PubMed ID: 16476029
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
Ignelzi MA; Wang W; Young AT
J Bone Miner Res; 2003 Apr; 18(4):751-9. PubMed ID: 12674336
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular bases of syndromic craniosynostoses.
Bonaventure J; El Ghouzzi V
Expert Rev Mol Med; 2003 Jan; 5(4):1-17. PubMed ID: 14987407
[TBL] [Abstract][Full Text] [Related]
7. Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signalling pathways.
Morriss-Kay GM; Iseki S; Johnson D
Novartis Found Symp; 2001; 232():102-16; discussion 116-21. PubMed ID: 11277075
[TBL] [Abstract][Full Text] [Related]
8. Roles of FGF signaling in skeletal development and human genetic diseases.
Chen L; Deng CX
Front Biosci; 2005 May; 10():1961-76. PubMed ID: 15769677
[TBL] [Abstract][Full Text] [Related]
9. [Genetics of craniofacial development].
van Adrichem LN; Hoogeboom AJ; Wolvius EB
Ned Tijdschr Tandheelkd; 2008 Feb; 115(2):61-8. PubMed ID: 18326400
[TBL] [Abstract][Full Text] [Related]
10. Cellular signaling by fibroblast growth factor receptors.
Eswarakumar VP; Lax I; Schlessinger J
Cytokine Growth Factor Rev; 2005 Apr; 16(2):139-49. PubMed ID: 15863030
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
12. FGF signaling: its role in bone development and human skeleton diseases.
Su N; Du X; Chen L
Front Biosci; 2008 Jan; 13():2842-65. PubMed ID: 17981758
[TBL] [Abstract][Full Text] [Related]
13. Fgfr mRNA isoforms in craniofacial bone development.
Rice DP; Rice R; Thesleff I
Bone; 2003 Jul; 33(1):14-27. PubMed ID: 12919696
[TBL] [Abstract][Full Text] [Related]
14. FGF-FGFR Mediates the Activity-Dependent Dendritogenesis of Layer IV Neurons during Barrel Formation.
Huang JY; Lynn Miskus M; Lu HC
J Neurosci; 2017 Dec; 37(50):12094-12105. PubMed ID: 29097598
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for fibroblast growth factor receptor activation.
Mohammadi M; Olsen SK; Ibrahimi OA
Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
[TBL] [Abstract][Full Text] [Related]
16. Craniosynostosis: from a clinical description to an understanding of bone formation of the skull.
Lajeunie E; Catala M; Renier D
Childs Nerv Syst; 1999 Nov; 15(11-12):676-80. PubMed ID: 10603009
[TBL] [Abstract][Full Text] [Related]
17. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3.
Balek L; Gudernova I; Vesela I; Hampl M; Oralova V; Kunova Bosakova M; Varecha M; Nemec P; Hall T; Abbadessa G; Hatch N; Buchtova M; Krejci P
Bone; 2017 Dec; 105():57-66. PubMed ID: 28826843
[TBL] [Abstract][Full Text] [Related]
18. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
19. Genetic defects in the development of the skull vault in humans and mice.
Verdyck P; Wuyts W; Van Hul W
Crit Rev Eukaryot Gene Expr; 2006; 16(2):119-42. PubMed ID: 16749893
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
Eswarakumar VP; Ozcan F; Lew ED; Bae JH; Tomé F; Booth CJ; Adams DJ; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18603-8. PubMed ID: 17132737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
